They develop advanced genetic tests for various purposes, including prenatal, reproductive, neonatal, postnatal, oncology, cardiovascular, metabolic hereditary, and COVID-19 testing. With accredited laboratories and a multidisciplinary team of experts, NIPD Genetics applies proprietary tools to create safe, accurate, and affordable genetic tests. Founded in 2010, the company commercializes pioneering research in genetic testing, aiming to improve clinical management and therapy for genetic diseases. Their R&D department, consisting of distinguished scientists, evaluates patient needs and develops innovative tests with clinical impact. Led by experienced executives and advised by a board of directors, NIPD Genetics has a strong publication track record and has showcased its leadership at international scientific conferences.